![]() Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | ![]() LogicBio Therapeutics LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment. | ||
Founding Date | Founding Date 1994 | Founding Date 2018 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations Lexington, US HQ Louisville, US |
Employees | Employees 8174% decrease | Employees 188 | Employees 4178% increase |
Valuation ($) | Valuation ($) 96.2 m | Valuation ($) 243.3 m | Valuation ($) 176.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $114.2m (FY, 2025) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $5.4m (FY, 2021) |
Net income | Net income ($3.1m) (FY, 2025) | Net income ($274.4m) (FY, 2025) | Net income ($40m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised $ 171.1m | Total funding raised N/A | Total funding raised $ 49m |

Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View company
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
View company